Compound-Protein Interaction Models for Flexible Bioactivity Prediction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional machine learning systems for predicting biological interactions between compounds and proteins suffer from inaccuracies, inefficiencies, and operational inflexibility, particularly in generating bioactivity predictions and identifying underlying biological drivers.

Innovation Solution

A protein interaction learning system utilizes a compound-protein interaction machine learning model to generate a machine learning representation, which trains target machine learning models to predict bioactivity results and identifies contributing proteins through explainability models, employing techniques like clustering, normalization, and similarity measures to improve accuracy and flexibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If conventional machine learning systems use large volumes of training data to predict biological interactions, then they can generate predictions, but they suffer from inaccuracies and inefficiencies

Engineering Contradiction:
Improveprediction accuracyVSAvoidcomputational efficiency
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent introduces compound-protein machine learning representations as an intermediary layer between raw training data and final bioactivity predictions. These representations encode interaction patterns in a compressed format, serving as a mediator that improves prediction accuracy while reducing the computational burden of processing large volumes of raw data.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system transforms the parameter space by converting raw compound-protein interaction data into machine learning representations with optimized dimensionalities. This parameter transformation enables more accurate predictions by capturing essential interaction patterns while reducing the complexity of the original high-dimensional data.

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If conventional systems implement machine learning models for bioactivity predictions, then they can generate predictions, but they lack operational flexibility

Engineering Contradiction:
Improveoperational flexibilityVSAvoidsystem complexity
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The compound-protein machine learning representations serve multiple functions: they can be used for training target machine learning models, generating predictions for various bioactivity endpoints, and providing explainability insights. This multi-functionality increases operational flexibility without proportionally increasing system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The system performs preliminary action by pre-computing compound-protein machine learning representations that capture essential interaction patterns. These pre-computed representations can then be reused across different prediction tasks and models, reducing the need for retraining and improving operational flexibility.

Inventive Principle:
Principle #10Preliminary action

3Loss of information

If the system generates detailed bioactivity predictions and identifies contributing proteins, then it provides comprehensive insights, but it requires extensive computational resources

Engineering Contradiction:
Improvebiological mechanism identificationVSAvoidcomputational resource consumption
Core Design Contradiction:
Loss of informationVSUse of energy by moving object

Solution Approach 1:

The patent extracts only the most relevant information from compound-protein interactions by generating machine learning representations that capture essential patterns. This extraction approach provides sufficient biological mechanism identification without processing all raw interaction data, thereby reducing computational resource consumption.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The system applies partial action by using a subset of the full interaction data space through machine learning representations. These representations capture the necessary biological mechanisms while excluding redundant information, achieving effective protein contribution identification with reduced computational effort.

Inventive Principle:
Principle #16Partial or excessive action

Data Source

PatentUS12462903B2Utilizing compound-protein machine learning representations to generate bioactivity predictions
Publication Date: 2025.11.04 RECURSION PHARMACEUTICALS INC
  • US12462903B2 patent drawing
  • US12462903B2 patent drawing
  • US12462903B2 patent drawing

AI summary

The present disclosure relates to systems, non-transitory computer-readable media, and methods that utilizing compound-protein machine learning representations to generate target results. For example, the disclosed systems can utilize a compound-protein interaction machine learning model to generate a compound-protein machine learning representation for compound protein pairs. The disclosed systems can utilize the compound-protein machine learning representation to train and utilize other target machine learning models in generating predicted bioactivity results. For example, the disclosed systems train a target machine learning model from compound-protein machine learning representations to generate ADMET predictions and/or biological perturbation program predictions. Furthermore, the disclosed systems can utilize one or more explainability models in conjunction with target machine learning models trained based on compound-protein machine learning representations to identify proteins that contribute to predicted bioactivity results.